Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
About Cordyceps Sunshine Biotech Holdings Co., Ltd.
CORDYCEPS SNSHINE BIO HLD
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.2M
- Net income
- -$154.8K
- Total assets
- $4.7M
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Stock Price
- Reported a net loss of $154.8K in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cordyceps Sunshine Biotech Holdings Co., Ltd..
Write a review
Cordyceps Sunshine Biotech Holdings Co., Ltd.: frequently asked questions
Is Cordyceps Sunshine Biotech Holdings Co., Ltd. an American company?
Cordyceps Sunshine Biotech Holdings Co., Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Cordyceps Sunshine Biotech Holdings Co., Ltd. publicly traded?
Yes — Cordyceps Sunshine Biotech Holdings Co., Ltd. is a publicly traded company. Its stock trades under the ticker symbol RAJAF on the OTC.
What does Cordyceps Sunshine Biotech Holdings Co., Ltd. do?
Cordyceps Sunshine Biotech Holdings Co., Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.
